Lyell Immunopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LYEL and other ETFs, options, and stocks.About LYEL
Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D.
CEOLynn Seely
CEOLynn Seely
Employees300
Employees300
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2018
Founded2018
Employees300
Employees300
LYEL Key Statistics
Market cap538.09M
Market cap538.09M
Price-Earnings ratio-1.11
Price-Earnings ratio-1.11
Dividend yield—
Dividend yield—
Average volume60.46K
Average volume60.46K
High today$25.59
High today$25.59
Low today$21.39
Low today$21.39
Open price$22.48
Open price$22.48
Volume92.68K
Volume92.68K
52 Week high$25.59
52 Week high$25.59
52 Week low$7.65
52 Week low$7.65
Stock Snapshot
The current Lyell Immunopharma(LYEL) stock price is $25.46, with a market capitalization of 538.09M. The stock trades at a price-to-earnings (P/E) ratio of -1.11.
During the trading session on 2025-12-04, Lyell Immunopharma(LYEL) shares reached a daily high of $25.59 and a low of $21.39. At a current price of $25.46, the stock is +19.0% higher than the low and still -0.5% under the high.
Trading volume for Lyell Immunopharma(LYEL) stock has reached 92.68K, versus its average volume of 60.46K.
The stock's 52-week range extends from a low of $7.65 to a high of $25.59.
The stock's 52-week range extends from a low of $7.65 to a high of $25.59.
People also own
Based on the portfolios of people who own LYEL. This list is generated using Robinhood data, and it’s not a recommendation.